Transparency Market Research
Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020
Published Date 30-Oct-2014
84 Page Report
Buy Now
Request Sample
Press Release Preimplantation Genetic Diagnosis Market in 2020: Transparency Market Research
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
REPORT DESCRIPTION
Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020 Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader range of indications due to advancements in the medical technology. These indications include chromosomal aberrations, genetic abnormalities, gender selection, HLA typing, X-linked diseases and single gene diseases. Demand for PGD is continuously increasing in patients who undergo IVF in the hope that it would improve the probability of live birth and reduce the chances of disabilities and genetic disorders in the offspring. Browse the Preimplantation Genetic Diagnosis Market Research Report at http://www.transparencymarketresearch.com/preimplantation-genetic-diagnosis-market.html This report provides in-depth analysis of the preimplantation genetic diagnosis market and its test types across various regions. Stakeholders in the report include diagnostic laboratories that provide PGD services, companies involved in the production of diagnosis kits and sequencers for PGD, and prospective market players planning to enter the market. The report comprises executive summary, which offers a market snapshot that covers the overall information about various types of tests in the PGD market. The market overview section explains market dynamics such as drivers, restraints and opportunities that influence the current and future status of the preimplantation genetic diagnosis market. Impact factors such as market attractiveness analysis and regulatory framework of PGD in various countries has been included in this section in order to provide a thorough analysis of the overall competitive scenario of the global preimplantation genetic diagnosis market. The report covers competitive analysis, which includes heat map analysis by key market players. Through heat map analysis, the stakeholder would be able to identify the presence of players across various segments of the market. All these factors would help market players gain a thorough understanding of the overall competitive scenario. The market players can then decide upon the business strategies and plans to be implemented in order to strengthen their position in the global market. Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=427 The global preimplantation genetic diagnosis market has been differentiated based on the types of tests and geographies. Based on the types of tests, the global preimplantation genetic diagnosis market has been segmented into six categories: PGD for chromosomal aberrations, aneuploidy screening, X-linked diseases, single gene disorder, HLA typing and gender selection. A detailed market analysis of the segments mentioned above has been provided at the global level in this study. The market analysis is based on market size and forecast in terms of USD million for the period 2013 to 2020 along with the compounded annual growth rate (CAGR %) for the period 2014 to 2020, considering 2013 as the base year. Browse More Medical Devices Related Research Reports at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
Geographically, the global preimplantation genetic diagnosis market has been categorized into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). This section further provides market size and forecast for various types of PFD tests in each region. The market size and forecast of the regional markets is provided for the period 2012 to 2020. CAGR (%) for each region is also estimated for the period 2014 to 2020, considering 2013 as the base year. The report also includes strategic recommendations, which would help market players sustain and grow in the highly competitive market. These recommendations would also help new entrants establish a strong position in the global preimplantation genetic diagnosis market. Company profiles section comprises key information such as company overview, financial overview, product portfolio, business strategies and recent developments about major players operating in the preimplantation genetic diagnosis market. Key players profiled in the report include Genesis Genetics, Genea Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Reprogenetics LLC and Reproductive Genetics Institute.
TABLE OF CONTENT Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.4 Research Methodology 1.5 List of Abbreviations
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Preimplantation Genetic Diagnosis Market 2.2 Comparative Analysis: Global Preimplantation Genetic Diagnosis Market, by Geography, 2013 & 2020 (Value %)
Chapter 3 Global Preimplantation Genetic Diagnosis Market Overview 3.1 Introduction 3.1.1 Preimplantation Genetic Diagnosis Process 3.1.2 Preimplantation Genetic Diagnosis Applications 3.2 Market Dynamics
3.2.1 Market Drivers 3.2.1.1 Delay in conception results in increased demand of PGD among higher age women 3.2.1.2 Increasing incidence rates of genetic diseases influencing patients to undergo PGD cycles for disease free offspring 3.2.1.3 Lifestyle hazards such as smoking, stress and pollution are leading to decreased fertility resulting in increased demand for IVF and PGD 3.2.2 Market Restraints 3.2.2.1 Economic and social factors associated with IVF restrains the PGD market 3.2.2.2 Limited insurance coverage for IVF and PGD results in less patient pool 3.2.3 Market Opportunities 3.2.3.1 Innovation in cancer prevention will increase the demand for PGD during forecast period 3.2.3.2 Advancement in the field of genetics will propel the growth of PGD market
Browse the Preimplantation Genetic Diagnosis Market Research Report at http://www.transparencymarketresearch.com/preimplantation-genetic-diagnosis-market.html
3.3 Regulatory Framework: Preimplantation Genetic Diagnosis 3.4 Porter’s Five Forces Analysis for the Global Preimplantation Genetic Diagnosis Market 3.4.1 Bargaining Power of Suppliers 3.4.2 Bargaining Power of Buyers 3.4.3 Threat of New Entrants 3.4.4 Threat of Substitutes 3.4.5 Competitive Rivalry 3.5 Market Attractiveness Analysis: Global Preimplantation Genetic Diagnosis Market, by Geography
3.6 Competitive Landscape 3.6.1 Heat Map Analysis for Key Market Players of Global Preimplantation Genetic Diagnosis Market
Chapter 4 Global Preimplantation Genetic Diagnosis Market, by Test Type 4.1 Overview 4.1.1 Global Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million) 4.2 Comparative Analysis: Global Preimplantation Genetic Diagnosis Market, by Test Type, 2013 & 2020 (Value %) 4.3 PGD for Chromosomal Aberrations 4.3.1 Global PGD for Chromosomal Aberrations Market Revenue, 2012 – 2020 (USD Million) 4.4 PGD for Aneuploidy Screening 4.4.1 Global PGD for Aneuploidy Screening Market Revenue, 2012 – 2020 (USD Million) 4.5 PGD for Gender Selection 4.5.1 Global PGD for Gender Selection Market Revenue, 2012 – 2020 (USD Million) 4.6 PGD for Single Gene Disorder 4.6.1 Global PGD for Single Gene Disorder Market Revenue, 2012 – 2020 (USD Million) 4.7 PGD for HLA Typing 4.7.1 Global PGD for HLA Typing Market Revenue, 2012 – 2020 (USD Million) 4.8 PGD for X-linked diseases 4.8.1 Global PGD for X-linked Diseases Market Revenue, 2012 – 2020 (USD Million)
Chapter 5 Preimplantation Genetic Diagnosis Market, by Geography 5.1 Overview
5.1.1 Global Preimplantation Genetic Diagnosis Market Revenue, by Geography, 2012 – 2020 (USD Million) 5.2 North America 5.2.1 North America Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million) 5.2.2 North America Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million) 5.3 Europe 5.3.1 Europe Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million) 5.3.2 Europe Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million) 5.4 Asia Pacific 5.4.1 Asia Pacific Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million) 5.4.2 Asia Pacific Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million) 5.5 Rest of the World (RoW) 5.5.1 Rest of the World Preimplantation Genetic Diagnosis Market Revenue, 2012 – 2020 (USD Million) 5.5.2 Rest of the World Preimplantation Genetic Diagnosis Market Revenue, by Test Type, 2012 – 2020 (USD Million)
Chapter 6 Recommendations 6.1 Introduction of Innovative Technologies to Reduce the Cost of Equipment and Procedure 6.2 Draw from Rapidly Growing CRAMS Market in Emerging Economies
Chapter 7 Company Profiles
7.1 Genesis Genetics 7.1.1 Company Overview 7.1.2 Financial Overview 7.1.3 Product Portfolio 7.1.4 Business Strategies 7.1.5 Recent Developments 7.2 Genea Ltd. 7.2.1 Company Overview 7.2.2 Financial Overview 7.2.3 Product Portfolio 7.2.4 Business Strategies 7.2.5 Recent Developments
Browse the Preimplantation Genetic Diagnosis Market Research Report at http://www.transparencymarketresearch.com/preimplantation-genetic-diagnosis-market.html
7.3 Illumina, Inc. 7.3.1 Company Overview 7.3.2 Financial Overview 7.3.3 Product Portfolio 7.3.4 Business Strategies 7.3.5 Recent Developments 7.4 Laboratory Corporation of America Holdings (LabCorp) 7.4.1 Company Overview 7.4.2 Financial Overview
7.4.3 Product Portfolio 7.4.4 Business Strategies 7.4.5 Recent Developments 7.5 Natera, Inc. 7.5.1 Company Overview 7.5.2 Financial Overview 7.5.3 Product Portfolio 7.5.4 Business Strategies 7.5.5 Recent Developments 7.6 PerkinElmer, Inc. 7.6.1 Company Overview 7.6.2 Financial Overview 7.6.3 Product Portfolio 7.6.4 Business Strategies 7.6.5 Recent Developments 7.7 Quest Diagnostics, Inc. 7.7.1 Company Overview 7.7.2 Product Portfolio 7.7.3 Financial Overview 7.7.4 Business Strategies 7.7.5 Recent Developments
Browse the Preimplantation Genetic Diagnosis Market Research Report at http://www.transparencymarketresearch.com/preimplantation-genetic-diagnosis-market.html
7.8 Reprogenetics LLC 7.8.1 Company Overview 7.8.2 Financial Overview 7.8.3 Product Portfolio 7.8.4 Business Strategies 7.8.5 Recent Developments 7.9 Reproductive Genetics Institute 7.9.1 Company Overview 7.9.2 Financial Overview 7.9.3 Product Portfolio 7.9.4 Business Strategies 7.9.5 Recent Developments About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Blog: http://tmrresearch.wordpress.com/